United Kingdom
# |
Name |
Free Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 6.57 B
|
Dec. 31, 2023 | USD 129.77 | -1.69% |
|
United Kingdom |
|
2 |
USD 5.63 B
|
Dec. 31, 2023 | USD 15.79 | -2.73% |
|
United Kingdom |
|
3 |
USD 2.78 B
|
Dec. 31, 2023 | USD 59.37 | -0.51% |
|
United Kingdom |
|
4 |
USD 2.55 B
|
Dec. 31, 2023 | USD 45.94 | 0.03% |
|
United Kingdom |
|
5 |
USD 2.24 B
|
Dec. 31, 2023 | USD 4.48 | -0.21% |
|
United Kingdom |
|
6 |
USD 501.70 M
|
Dec. 31, 2023 | USD 5.03 | -1.57% |
|
United Kingdom |
|
7 |
USD 439.00 M
|
Dec. 31, 2023 | USD 24.44 | -0.21% |
|
United Kingdom |
|
8 |
USD 420.67 M
|
March 31, 2024 | USD 32.51 | 0.69% |
|
United Kingdom |
|
9 |
USD 238.20 M
|
Dec. 31, 2023 | USD 2.80 | 1.24% |
|
United Kingdom |
|
10 |
USD 181.00 M
|
Dec. 31, 2023 | USD 11.94 | -0.50% |
|
United Kingdom |
|
11 |
USD 64.12 M
|
July 31, 2024 | USD 0.16 | -0.69% |
|
United Kingdom |
|
12 |
USD 42.70 M
|
Sept. 30, 2024 | USD 18.48 | 0.49% |
|
United Kingdom |
|
13 |
USD 39.93 M
|
Dec. 31, 2023 | USD 47.63 | 0.66% |
|
United Kingdom |
|
14 |
USD 39.08 M
|
Dec. 31, 2023 | USD 0.75 | -0.07% |
|
United Kingdom |
|
15 |
USD 31.26 M
|
June 30, 2024 | USD 9.99 | -0.88% |
|
United Kingdom |
|
16 |
USD 20.60 M
|
Sept. 30, 2024 | USD 5.40 | -1.25% |
|
United Kingdom |
|
17 |
USD 19.35 M
|
March 31, 2024 | USD 2.90 | -3.96% |
|
United Kingdom |
|
18 |
USD 17.52 M
|
Dec. 31, 2023 | USD 0.78 | 0.09% |
|
United Kingdom |
|
19 |
USD 15.35 M
|
Dec. 31, 2023 | USD 0.21 | 6.16% |
|
United Kingdom |
|
20 |
USD 14.38 M
|
Dec. 30, 2023 | USD 72.03 | -1.91% |
|
United Kingdom |
|
21 |
USD 12.73 M
|
June 30, 2024 | USD 4.76 | -2.41% |
|
United Kingdom |
|
22 |
USD 10.94 M
|
Dec. 31, 2023 | USD 6.20 | -2.97% |
|
United Kingdom |
|
23 |
USD 10.80 M
|
June 30, 2024 | USD 39.06 | 2.49% |
|
United Kingdom |
|
24 |
USD 9.83 M
|
Dec. 31, 2023 | USD 2.92 | -0.33% |
|
United Kingdom |
|
25 |
USD 7.40 M
|
Dec. 31, 2023 | USD 0.46 | 0.09% |
|
United Kingdom |
|
26 |
USD 6.24 M
|
March 31, 2024 | USD 0.78 | -0.69% |
|
United Kingdom |
|
27 |
USD 5.06 M
|
April 30, 2024 | USD 0.64 | 0.47% |
|
United Kingdom |
|
28 |
USD 3.18 M
|
Dec. 31, 2023 | USD 2.66 | 14.48% |
|
United Kingdom |
|
29 |
USD 1.45 M
|
Dec. 31, 2023 | USD 0.32 | 0.09% |
|
United Kingdom |
|
30 |
USD 1.30 M
|
June 30, 2024 | USD 1.47 | -0.73% |
|
United Kingdom |
|
31 |
USD 482.14 K
|
Jan. 31, 2024 | USD 0.16 | 0.87% |
|
United Kingdom |
|
32 |
USD 372.51 K
|
Sept. 30, 2023 | USD 0.04 | 0.09% |
|
United Kingdom |
|
33 |
USD 177.00 K
|
Dec. 31, 2023 | USD 0.70 | -2.31% |
|
United Kingdom |
|
34 |
USD -844.83 K
|
Dec. 31, 2023 | USD 0.31 | 0.09% |
|
United Kingdom |
|
35 |
USD -913.53 K
|
Dec. 31, 2023 | USD 0.05 | 1.50% |
|
United Kingdom |
|
36 |
USD -1.19 M
|
Dec. 31, 2023 | USD 0.37 | -1.16% |
|
United Kingdom |
|
37 |
USD -1.33 M
|
Dec. 31, 2023 | USD 0.13 | -2.30% |
|
United Kingdom |
|
38 |
USD -1.50 M
|
Dec. 31, 2023 | USD 1.53 | -6.13% |
|
United Kingdom |
|
39 |
USD -1.74 M
|
Dec. 31, 2023 | USD 0.04 | -14.59% |
|
United Kingdom |
|
40 |
USD -1.75 M
|
March 31, 2024 | USD 0.15 | 0.09% |
|
United Kingdom |
|
41 |
USD -1.94 M
|
Dec. 31, 2023 | USD 0.21 | 0.09% |
|
United Kingdom |
|
42 |
USD -2.11 M
|
Dec. 31, 2023 | USD 0.02 | 2.68% |
|
United Kingdom |
|
43 |
USD -2.15 M
|
June 30, 2024 | USD 0.10 | 0.09% |
|
United Kingdom |
|
44 |
USD -2.23 M
|
March 31, 2024 | USD 0.11 | -6.40% |
|
United Kingdom |
|
45 |
USD -2.27 M
|
Dec. 31, 2023 | USD 0.04 | -9.47% |
|
United Kingdom |
|
46 |
USD -2.48 M
|
Dec. 31, 2023 | USD 28.56 | -4.90% |
|
United Kingdom |
|
47 |
USD -2.95 M
|
Sept. 30, 2024 | USD 0.14 | 0.09% |
|
United Kingdom |
|
48 |
USD -3.70 M
|
June 30, 2024 | USD 0.19 | -3.04% |
|
United Kingdom |
|
49 |
USD -4.81 M
|
June 30, 2024 | USD 0.03 | -4.36% |
|
United Kingdom |
|
50 |
USD -4.96 M
|
June 30, 2024 | USD 0.27 | 2.36% |
|
United Kingdom |
The Pharmaceuticals company in United Kingdom with the highest Free Cash Flow is AstraZeneca PLC (LSE: AZN.L) at USD 6.57 B.
The Pharmaceuticals company in United Kingdom with the lowest Free Cash Flow is Roivant Sciences Ltd. (NasdaqGS: ROIV) at USD -766.65 M.
The top 10 Pharmaceuticals companies in United Kingdom by Free Cash Flow are AstraZeneca PLC, GSK plc, Reckitt Benckiser Group plc, RELX PLC, Haleon plc, Clarivate Plc, Hikma Pharmaceuticals PLC, Halma plc, ConvaTec Group Plc and Smith & Nephew plc.
The bottom 10 Pharmaceuticals companies in United Kingdom by Free Cash Flow are Roivant Sciences Ltd., Centessa Pharmaceuticals plc, Autolus Therapeutics plc, COMPASS Pathways plc, Bicycle Therapeutics plc, Barinthus Biotherapeutics plc, Shield Therapeutics plc, Verona Pharma plc, Silence Therapeutics plc and Oxford Biomedica plc.